drugset / Trial / NCT00199966

Safety And Efficacy Study Of Depakote ER To Treat Pediatric Bipolar Disorder

NCT00199966

Phase 4 Completed 30 enrolled Medical College of Wisconsin
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this research is to compare how safely and how well this medicine works in treating children and teenagers between the ages of 6 and 17 years with a diagnosis of Bipolar Disorder.

Timeline

Start
2003-12
Primary completion
Completion
2005-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Divalproex Sodium Small molecule

Indications